Anti-aminoacyl tRNA synthetase immune responses: insights into the pathogenesis of the idiopathic inflammatory myopathies
- 1 November 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Rheumatology
- Vol. 15 (6) , 708-713
- https://doi.org/10.1097/00002281-200311000-00005
Abstract
One of the most striking humoral characteristics of the idiopathic inflammatory myopathies is the specific targeting of components of the translational machinery by the immune system. The most commonly targeted of these components are the aminoacyl tRNA synthetase (ARS) molecules. However, the relation between the immune responses to these molecules and the pathogenesis of the inflammatory myopathies remains obscure. This review will examine recent evidence that explores the links between the ARS molecules, inflammation, and apoptosis, with the aim of furthering our current understanding of the underlying pathogenesis of the myositis syndromes. Several of the ARS molecules and their proteolytic fragments generated during inflammation and apoptosis have recently been shown to possess chemoattractant properties. The liberation of these fragments in the muscle microenvironment under certain circumstances may provide a proinflammatory context and lead to the influx of lymphocytes, macrophages, and specialized antigen-presenting cells to the site of muscle injury. The subsequent processing and presentation of these autoantigen fragments on major histocompatibility complex class I and II molecules may generate an ARS-specific autoimmune response, which may be responsible for amplification and propagation of muscle injury in these diseases. The striking association between the inflammatory myopathies and anti-ARS antibodies implies a role for the ARS molecules in the pathogenesis of these syndromes. Recent data suggest that ARS molecules and their proteolytic fragments generated during the cell death process may be responsible for priming and sustaining a specific immune response in situ in myositis. How these molecules become altered and access the immune system in the disease microenvironment is an area of ongoing investigation.Keywords
This publication has 39 references indexed in Scilit:
- Delayed Apoptotic Cell Clearance and Lupus-like Autoimmunity in Mice Lacking the c-mer Membrane Tyrosine KinaseThe Journal of Experimental Medicine, 2002
- Interaction Network of Human Aminoacyl-tRNA Synthetases and Subunits of Elongation Factor 1 ComplexBiochemical and Biophysical Research Communications, 2002
- The N-terminal Domain of Mammalian Lysyl-tRNA Synthetase Is a Functional tRNA-binding DomainJournal of Biological Chemistry, 2002
- Human anti‐asparaginyl‐tRNA synthetase autoantibodies (anti‐KS) increase the affinity of the enzyme for its tRNA substrateFEBS Letters, 2001
- Myositis Induced by Naked DNA Immunization with the Gene for Histidyl-tRNA SynthetaseHuman Gene Therapy, 1997
- The Instructive Role of Innate Immunity in the Acquired Immune ResponseScience, 1996
- Autoantibodies to glycyl–transfer RNA synthetase in myositis. Association with dermatomyositis and immunologic heterogeneityArthritis & Rheumatism, 1996
- Long Charge-Rich α-Helices in Systemic AutoantigensBiochemical and Biophysical Research Communications, 1993
- Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase.Journal of Clinical Investigation, 1993
- Origin and regulation of a disease-specific autoantibody response. Antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 autoantibodies.Journal of Clinical Investigation, 1990